014 Apremilast in psoriasis - a prospective real-world study
نویسندگان
چکیده
منابع مشابه
Erythrodermic Psoriasis Treated with Apremilast
Erythroderma is a rare potentially deadly exfoliative dermatitis characterized by diffuse cutaneous erythema which may be associated with multi-organ dysfunction. Therefore, it is imperative to recognize and treat it promptly. Erythrodermic psoriasis is the most common form of erythroderma. Management of this condition is largely based on aggressive supportive care and the use of anti-inflammat...
متن کاملPediatric psoriasis treated with apremilast
BSA: body surface area INTRODUCTION Psoriasis is a cutaneous, chronic inflammatory disorder that affects approximately 3.1% of US adults younger than 60 years and up to 2.1% of children worldwide. Chronic plaque psoriasis is generally the most common type of childhood psoriasis (accounting for 74% of cases in one study), followed by guttate psoriasis (9.7%-28.9%), which is often triggered by st...
متن کاملApremilast in the treatment of moderate-to-severe plaque psoriasis:
2015 Psoriasis is a chronic, systemic inflammatory disease that often has a negative impact on daily functioning and quality of life. Although many treatment options are available, patients are often dissatisfied with their current disease management. Apremilast, an oral PDE4 inhibitor, was recently approved in multiple countries for the treatment of patients with active psoriatic arthritis and...
متن کاملA Real-World Study to Assess the Effectiveness of Itolizumab in Patients with Chronic Plaque Psoriasis
BACKGROUND While clinical trial data on the efficacy of itolizumab in the management of psoriasis is relatively well documented, data on the effectiveness of this humanized IgG1 monoclonal antibody in real-world settings is sparse. AIMS The current study assessed the effectiveness of itolizumab in real-world settings. MATERIALS AND METHODS This study assessed psoriasis area severity index (...
متن کاملRecurrence of Melanoma after Starting Apremilast for Psoriasis
This is a report on a 32-year-old man with a history of two previous melanomas with concurrent plaque-type psoriasis. His history dates to 2009, when he was diagnosed with his first melanoma on the right occiput, Clark's level IV, tumor thickness 1.53 mm, nonulcerated, mitotic index 1/mm2. He subsequently developed nodal recurrence after an initial negative sentinel lymph node biopsy and was tr...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Investigative Dermatology
سال: 2017
ISSN: 0022-202X
DOI: 10.1016/j.jid.2017.07.110